Mediclin AG
XHAM:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XHAM:MED
Watchlist
Price: 2.9 EUR -2.03% Market Closed
Market Cap: 207.7m EUR

Intrinsic Value

The intrinsic value of one MED stock under the Base Case scenario is 20.14 EUR. Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MED Intrinsic Value
20.14 EUR
Undervaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Mediclin AG

MED
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MED cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Mediclin AG
XHAM:MED
DE
Health Care
Market Cap
207.7m EUR
IPO
Dec 4, 2000
DE
Health Care
Market Cap
207.7m EUR
IPO
Dec 4, 2000
Price
€false
EPS
€false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MED?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Mediclin AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mediclin AG

Current Assets 319.3m
Cash & Short-Term Investments 193.2m
Receivables 113.3m
Other Current Assets 12.8m
Non-Current Assets 584.8m
Long-Term Investments 60.9k
PP&E 518.2m
Intangibles 22.1m
Other Non-Current Assets 44.4m
Efficiency

Free Cash Flow Analysis
Mediclin AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mediclin AG

Revenue
771.1m EUR
Cost of Revenue
-129.6m EUR
Gross Profit
641.5m EUR
Operating Expenses
-623.7m EUR
Operating Income
17.8m EUR
Other Expenses
-29m EUR
Net Income
-11.2m EUR
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROIC is Increasing
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
33/100
Solvency
Score

Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Mediclin AG

Wall Street analysts forecast MED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 4.59 EUR with a low forecast of 3.84 EUR and a high forecast of 5.46 EUR.

Lowest
Price Target
3.84 EUR
32% Upside
Average
Price Target
4.59 EUR
58% Upside
Highest
Price Target
5.46 EUR
88% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 20.14 EUR.

Is MED stock undervalued or overvalued?

Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 86%.

Back to Top